A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 20
- Registration Number
- NCT00000667
- Locations
- 🇺🇸
NY Univ. HIV/AIDS CRS, New York, New York, United States
Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-02
- Target Recruit Count
- 54
- Registration Number
- NCT00000646
- Locations
- 🇺🇸
Case CRS, Cleveland, Ohio, United States
🇺🇸Beth Israel Deaconess - East Campus A0102 CRS, Boston, Massachusetts, United States
Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy
- Conditions
- HIV Infections
Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment
- Conditions
- HIV Infections
The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 140
- Registration Number
- NCT00001074
- Locations
- 🇺🇸
Julio Arroyo, West Columbia, South Carolina, United States
🇺🇸Johns Hopkins Hosp, Baltimore, Maryland, United States
🇺🇸Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States
Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox
- Conditions
- ChickenpoxHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 60
- Registration Number
- NCT00001125
- Locations
- 🇺🇸
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles, California, United States
🇺🇸Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases, Torrance, California, United States
🇺🇸HMS - Children's Hosp. Boston, Div. of Infectious Diseases, Boston, Massachusetts, United States
Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma
- Conditions
- HIV InfectionsSarcoma, Kaposi
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-02
- Target Recruit Count
- 36
- Registration Number
- NCT00000695
- Locations
- 🇺🇸
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
🇺🇸UCLA CARE Ctr, Los Angeles, California, United States
🇺🇸Northwestern Univ Med School, Chicago, Illinois, United States
A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants
- Conditions
- HIV InfectionsPregnancy
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 2009
- Registration Number
- NCT00001135
- Locations
- 🇺🇸
Children's Hosp of Boston, Boston, Massachusetts, United States
🇺🇸Univ of Miami (Pediatric), Miami, Florida, United States
🇺🇸Duke Univ Med Ctr, Durham, North Carolina, United States
Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals
- Conditions
- HIV Infections
Effect of Interleukin-2 on HIV Treatment Interruption
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 80
- Registration Number
- NCT00015704
- Locations
- 🇺🇸
UCLA CARE Center CRS, Los Angeles, California, United States
🇺🇸San Mateo County AIDS Program, San Mateo, California, United States
🇺🇸St. Louis ConnectCare, Infectious Diseases Clinic, Saint Louis, Missouri, United States